Evangelos Terpos
Title
Cited by
Cited by
Year
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
22122014
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors
A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ...
J Clin Oncol 23 (34), 8580-7, 2005
13542005
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
AV Jones, S Kreil, K Zoi, K Waghorn, C Curtis, L Zhang, J Score, R Seear, ...
Blood 106 (6), 2162-2168, 2005
10342005
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
8392016
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
7052012
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
MA Dimopoulos, E Kastritis, C Bamia, I Melakopoulos, D Gika, M Roussou, ...
Annals of Oncology 20 (1), 117-120, 2009
4302009
Soluble receptor activator of nuclear factor ęB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index
E Terpos, R Szydlo, JF Apperley, E Hatjiharissi, M Politou, J Meletis, ...
Blood 102 (3), 1064-1069, 2003
4162003
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ...
Blood 125 (13), 2068-2074, 2015
4152015
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ...
Annals of Oncology 28 (suppl_4), iv52-iv61, 2017
4132017
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ...
Journal of clinical oncology 28 (33), 4976-4984, 2010
4082010
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid
MA Dimopoulos, E Kastritis, A Anagnostopoulos, I Melakopoulos, D Gika, ...
haematologica 91 (7), 968-971, 2006
4072006
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients
K Zervas, E Verrou, Z Teleioudis, K Vahtsevanos, A Banti, D Mihou, ...
British journal of haematology 134 (6), 620-623, 2006
3552006
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
E Voskaridou, D Christoulas, A Bilalis, E Plata, K Varvagiannis, ...
Blood 115 (12), 2354-2363, 2010
3452010
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ...
Blood 118 (17), 4519-4529, 2011
3342011
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
M Dimopoulos, E Terpos, RL Comenzo, P Tosi, M Beksac, O Sezer, ...
Leukemia 23 (9), 1545-1556, 2009
3202009
International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease
E Terpos, G Morgan, MA Dimopoulos, MT Drake, S Lentzsch, N Raje, ...
Journal of clinical oncology 31 (18), 2347, 2013
3052013
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
A Lipton, R Cook, F Saad, P Major, P Garnero, E Terpos, JE Brown, ...
Cancer 113 (1), 193-201, 2008
2752008
Myeloma bone disease: pathophysiology and management
E Terpos, MA Dimopoulos
Annals of oncology 16 (8), 1223-1231, 2005
2732005
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement
MA Dimopoulos, J Hillengass, S Usmani, E Zamagni, S Lentzsch, ...
J Clin Oncol 33 (6), 657-664, 2015
2512015
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, PI Croucher, R García-Sanz, M Boccadoro, ...
Annals of Oncology 20 (8), 1303-1317, 2009
2402009
The system can't perform the operation now. Try again later.
Articles 1–20